360MarketUpdates™ distinguish Canvax as leading Glutamate Receptor Manufacturer
The prestiguous Market Research company, 360MarketUpdates™, have distinguish Canvax as leading Glutamate Receptor Manufacturer in their last Glutamate Receptor-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data. Learn more about Glutamate Receptor Market.
BioCompare™ highlights Canvax™ as TOP Expert for Viral Biomanufacturing
To write this article, BioCompare™ selected a representative from the five companies, that in their opinion, are leading the Viral Vectors Research and Biomanufacturing sector Worldwide. Read the article. Learn more about pASSEMBLE™ Viral Packaging Systems.
Life Sciences Lab magazine analyses pSpark® I DNA Cloning vector´s high efficiency in relevant research
The technical study compares the efficiency of pSpark® I DNA cloning system, developed by Canvax Biotech, with the other two popular cloning systems present in the market for almost two decades. As shown in the study, pSpark® I DNA cloning system shows important advantages over the other products: higher efficiency (up to 18 times higher), […]
The Optimization of Canvax´s pSpark® DNA Cloning systems highlighted by all the national press
Today, the national press has highlighted that recent tests of the new version of Canvax´s pSpark® DNA Cloning systems have been successful, introducing significant progress and improvements over the original product. As described in the article, pSpark® is based on a new technology for cloning blunt fragments from PCR or outcome of treatment of double-stranded […]
Canvax develops a one million times more sensitive biosensor
Canvax Biotech has announced the development of a cellular biosensor that is one million times more sensitive than others previously developed by competitors. Some of its important benefits are that the biological system amplifies a one million times smaller signal emitted by a specimen. Also, the biosensor can detect more than one substance at a […]
Several pharmaceutical companies are interested in Canvax
In today’s edition, 20 Minutos newspaper highlights the interest of several multinational pharmaceutical companies in Canvax´s research applied to new drugs development and its proprietary technology to screen it. Also, the writer explains the beginnings of the company and its early stands, or the relationships with the investor group. For more details, read the full […]